相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R. Oakes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Navitoclax (ABT-263) Accelerates Apoptosis during Drug-Induced Mitotic Arrest by Antagonizing Bcl-xL
Jue Shi et al.
CANCER RESEARCH (2011)
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer
Qing Zhou et al.
INVESTIGATIONAL NEW DRUGS (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
David Karnak et al.
CURRENT DRUG TARGETS (2010)
Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
Margaret E. Harley et al.
EMBO JOURNAL (2010)
Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis
David T. Terrano et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response (Publication with Expression of Concern. See vol. 14, 2019)
Danupon Nantajit et al.
PLOS ONE (2010)
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
Brian J. Lestini et al.
CANCER BIOLOGY & THERAPY (2009)
Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis
Teresita Reiner et al.
CANCER LETTERS (2009)
Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
Ricardo M. Attar et al.
CLINICAL CANCER RESEARCH (2009)
Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2
Joshua L. Andersen et al.
EMBO JOURNAL (2009)
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
Melanie Mediavilla-Varela et al.
MOLECULAR CANCER (2009)
Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
Kevin Bray et al.
MOLECULAR CANCER RESEARCH (2009)
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
Paula Hauck et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
K. D. Mason et al.
LEUKEMIA (2009)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5
Jue Shi et al.
CANCER RESEARCH (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance
Meenakshi Upreti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
Jin H. Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
Theresa M. LaVallee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
Victoria Del Gaizo Moore et al.
BLOOD (2008)
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo
Min H. Kang et al.
BLOOD (2007)
Therapeutic options for hormone-refractory prostate cancer in 2007
Boris A. Hadaschik et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on Radiation Therapy Oncology Group protocol 92-02
Li Yan Khor et al.
CLINICAL CANCER RESEARCH (2007)
Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis
Lindsey A. Allan et al.
MOLECULAR CELL (2007)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
Shuang Chen et al.
CANCER RESEARCH (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo
Alex R. Shoemaker et al.
CANCER RESEARCH (2006)
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Lourdes A. Gomez et al.
MOLECULAR CANCER THERAPEUTICS (2006)
2-methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells
C Perez-Stable
CANCER LETTERS (2006)
Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis
M Berndtsson et al.
FEBS LETTERS (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Cell death by mitotic catastrophe: a molecular definition
M Castedo et al.
ONCOGENE (2004)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Lentivirus-delivered stable gene silencing by RNAi in primary cells
SA Stewart et al.
RNA (2003)
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma - Ki-67, bcl-2, bax, and bcl-x
A Pollack et al.
CANCER (2003)
Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis
A Basu et al.
FEBS LETTERS (2003)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)
Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery
Y Konishi et al.
MOLECULAR CELL (2002)
Analyzing mitochondrial changes during apoptosis
RA Gottlieb et al.
METHODS (2002)
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
DS O'Connor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
